Pyrvinium exhibited similar or even higher efficacy for p53 activation and p53-mediated cell apoptosis than the MDM2 inhibitor Nutlin-3a in TP53WT MCC cells. The gene discussed is MDM2; the disease is Merkel cell skin cancer.